Literature DB >> 6129799

Hepatic reactions during ketoconazole treatment.

P A Janssen, J E Symoens.   

Abstract

Silent and symptomatic hepatic reactions have occurred during ketoconazole treatment. The silent reactions (transient asymptomatic elevations of serum transaminase or alkaline phosphatase levels) may occur at any time during ketoconazole treatment. Asymptomatic increases in liver enzymes may also occur in a sizeable number of patients with fungal disease without any treatment. Symptomatic hepatic reactions have occurred mainly during the first few months of treatment. The estimated incidence of symptomatic reactions is of the order of 1 in 10,000.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6129799     DOI: 10.1016/0002-9343(83)90519-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  High-dose itraconazole in the treatment of severe mycoses.

Authors:  P K Sharkey; M G Rinaldi; J F Dunn; T C Hardin; R J Fetchick; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

Review 3.  Onychomycosis. Going for cure.

Authors:  A K Gupta; N H Shear
Journal:  Can Fam Physician       Date:  1997-02       Impact factor: 3.275

4.  Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group.

Authors: 
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

Review 5.  A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.

Authors:  A K Gupta; N H Shear
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

6.  Prolonged jaundice following ketoconazole-induced hepatic injury.

Authors:  G D Benson; P K Anderson; B Combes; K G Ishak
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

Review 7.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

8.  Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy.

Authors:  W Inman; G Pearce; L Wilton
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 9.  Treatment of precocious puberty in McCune-Albright syndrome.

Authors:  Jakub Mieszczak; Erica A Eugster
Journal:  Pediatr Endocrinol Rev       Date:  2007-08

10.  Ketoconazole impairs biliary excretory function in the isolated perfused rat liver.

Authors:  G B Gaeta; M F Tripodi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.